NASP is a keystone event for insights into specialty pharmacy care
STOUGHTON, MA, September 8, 2022–(BUSINESS WIRE)–Shields Health Solutions (Shields), the leading accelerator for specialty pharmacies in the country, today announced that it will host a session titled “The Evolution of Specialty Pharmacy” at the Hospital Health System Workshop at the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo in Kissimmee, Florida. In addition, Shields Pharmacists will present eight posters at the conference covering treating a range of specialized disease states, reducing the cost of specialist care and how integrated health systems can compare performance through reporting.
The NASP Annual Meeting & Expo brings together thought leaders and healthcare veterans for interactive learning, sharing best practices, and building partnerships in an interactive setting. NASP provides continuing education programs to pharmacists and other healthcare professionals working in specialty pharmacy. Members include specialty pharmacies, integrated health systems, pharmaceutical and biotechnology manufacturers, healthcare payers, group purchasing organizations (GPOs), wholesale distributors of pharmaceuticals and technology and other suppliers.
“The NASP conference is an annual industry highlight and we are excited to share insights from Shields partners during the hospital/health system workshop,” said Erin Hendrick, Shields Executive Vice President of Commercial Partnerships. “By sharing the evolution of specialty pharmacy from the perspective of the Shields health system partners, we hope to spark the conversation about where specialty pharmacy has been, where it is and where we need to go.”
Shields’ speaking session will take place during the Hospital and Health System Workshop on Monday, September 19 from 10:30-11:30 a.m. ET. Tim Affeldt, PharmD, Vice President, Specialty and Infusion Operations at M Health Fairview, will moderate the session, which will shed light on how the specialty pharmacy capacity can evolve to create more comprehensive patient care. The panel will consist of:
Gary Kerr, PharmD, MBA, Chief Pharmacy Officer at Baystate Health
Lisa Blanchette, PharmD, MHA, Senior Director of Infusion and Specialty Pharmacy Services at Novant Health
Brian Lounsbery, RPh, Director, Specialty and Compounding Pharmacy at Avera
Lesli Goebel, PharmD, Chief Pharmacist at Billings Clinic Specialty Pharmacy
See below for details on Shields’ clinical research poster presentations:
Topic: Evaluation and Reporting of Clinical Outcomes
Authors: Kristen Ditch, PharmD; Martha Stutsky, PharmD, BCPS; Carolkim Huynh, PharmD, CSP; Christopher Barr; Shreevidya Periyasamy, MS, HIA; Kate Smullen, PharmD, CSP, MSCS; Jennifer L. Donovan, PharmD
Overview: The aim is to describe a systematic approach for defining and reporting COs for multiple disease states in multiple specialty pharmacies for health systems.
Topic: Community of Practice for Specialist Pharmacies
Authors: Kuwan Blake, BA, CPhT; Dawn DiPasquale, CTDP, CPhT
Overview: The aim of this initiative is to describe the structure and functionality of the Communities of Practice (CoP) program and to demonstrate its impact on the operational statistics of specialist pharmacies.
Topic: Impact of an Outpatient Clinical Pharmacist Program on Coverage Determination Results for Specialist Oncology Drugs
Authors: Young Kim, PharmD; Martha Stutsky, PharmD, BCPS; Kate Smullen, PharmD, CSP, MSCS; Jennifer L. Donovan, PharmD
Overview: The aim was to evaluate the impact of an ambulatory clinical pharmacist program on the outcomes of third party coverage determination for specialty oncology drugs in cancer patients managed by an HSSP.
Topic: Factors Affecting CDK4/6 Inhibitor Adherence
Authors: Martha Stutsky, PharmD, BCPS; Shreevidya Periyasamy, MS, HIA; Kate Smullen, PharmD, CSP, MSCS; Andreas Argeros; Navya Clement, PharmD, BCPS, CSP; Diane Wolfe, RPh; Jennifer L. Donovan, PharmD
Overview: Several publications describe adherence and persistence with oral oncolytics, but there are limited reports analyzing factors associated with adherence to CDK4/6 inhibitors. The primary aim is to identify demographic factors that influence CDK4/6 inhibitor compliance.
Topic: Pharmacy Liaison-Managed Care Model in Diabetes
Authors: Martha Stutsky, PharmD, BCPS; Kristen Ditch, PharmD; Shreevidya Periyasamy, MS, HIA; Lillian Piz, MS; Carolkim Huynh, PharmD, CSP; Nicholas Bull, Pharm D; Jennifer L. Donovan, Pharm D; Gary Kerr, PharmD, MBA; Bill McElnea, MPP
Overview: The aim was to describe an observational analysis of a pharmacist-managed model of care for patients with diabetes and to measure its impact on drug access, adherence, and changes in hemoglobin A1C (HbA1c).
Topic: Integrated specialty model lowers pharmacy costs
Authors: Martha Stutsky, PharmD, BCPS; Dale Fasching, PharmD, MBA; Carolkim Huynh, PharmD, CSP; Jennifer L. Donovan, Pharm D; Brian S. Smith, PharmD
Overview: The aim was to evaluate pharmacy and medical costs in non-oncology specialty pharmacy patients in an HSSP group care model versus a national network using an anonymized database of 36 million Medicare Advantage members of the national health insurer.
Topic: Impact of an Embedded Rheumatology Pharmacist
Authors: Sefa Kploanyi, PharmD, BCPS; Kate Smullen, PharmD, CSP, MSCS; Martha Stutsky, PharmD, BCPS; Jennifer L. Donovan, PharmD
Overview: The aim of this project is to evaluate the impact of a pharmacist’s involvement on the outcomes of coverage determination, access to medication, and caregiver satisfaction for a rheumatology practice affiliated with an integrated specialty pharmacy of the health system.
Topic: Pharmacist Impact in a Multiple Sclerosis Clinic
Authors: Mekala Paparian, Pharm D; Kate Smullen, PharmD, CSP; Martha Stutsky, PharmD, BCPS
Overview: The aim was to demonstrate the impact of ambulatory inpatient pharmacists (ACP) in facilitating access to MS medications on pre-authorization (PA) turnaround times (TAT), drug attractiveness and PA approval rates, and satisfaction scores. from the clinic.
About Shields Health Solutions
Shields Health Solutions (ShieldsRx) is the leading accelerator for specialty pharmacies in the country. The Shields Performance Platform, an integrated suite of solutions, services and technology, is purposely designed to improve payer access and medicines for specialty pharmacies, improve health outcomes for complex patients and drive growth across the health system. As the pharmaceutical industry’s foremost experts on specialty health systems, Shields has a proven track record of success, including access to more than 80 percent of all limited distribution drugs (LDDs) and most of the country’s health insurance payers. ; and a clinical model proven to reduce total healthcare costs by 13%. Working with more than 70 health systems across the country through collaboration on a national scale, Shields has a vested interest in delivering measurable clinical and financial outcomes for health systems. For more information, visit our blog and follow us on social media, @ShieldsRxLinkedIn, Facebook and YouTube.
Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220908005123/en/
For Shields Health Solutions
Crystal Chuckel, Chief Marketing & Communications Officer
(262) 309 -2488